Q1 FY27 results: small profit, auditor flags GST concerns

Qualified OpinionGoing ConcernResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.6%Reaction day

₹89.82

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%+4.5% vs market

Pharmaceuticals peers, median of 167sector-0.4%+5.0% vs sector

On the reaction day the stock moved 4.5 pts more than Nifty Microcap 250 and 5.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.6+0.1+4.5-0.4+5.0

Next day

+0.2+0.5-0.3-0.0+0.2

+3.5-0.1+3.6-0.8+4.3

-1.4+0.4-1.8-0.4-1.0

+4.8+0.7+4.1-0.8+5.6

-0.9+0.9-1.9-0.5-0.4

-4.3+1.1-5.4-0.7-3.5

15d

-13.1+1.6-14.7+1.4-14.5

-18.2-0.7-17.5+0.6-18.8

+28.0-3.2+31.3-4.2+32.2

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 167Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved unaudited Q1 FY27 results (quarter ended June 30, 2026). Revenue from operations was Rs 7.46 lakh versus nil in Q1 FY26. The company swung to a small profit of Rs 2.10 lakh from a loss of Rs 11.80 crore in Q1 FY26. Full year FY26 loss stood at Rs 11.85 crore. Auditor SSRV & Associates issued a qualified review report flagging GST registration discrepancies. Reserves remain negative at Rs 20.19 lakh.

Likely market impact

Auditor qualified opinion on GST issues and negative reserves raise red flags despite the small Q1 profit.